Index RUT P/E - EPS (ttm) -0.61 Insider Own 3.71% Shs Outstand 49.71M Perf Week 8.63%
Market Cap 1.80B Forward P/E - EPS next Y -0.13 Insider Trans -2.05% Shs Float 47.88M Perf Month 1.92%
Enterprise Value 1.73B PEG - EPS next Q -0.10 Inst Own 97.18% Short Float 5.33% Perf Quarter -2.35%
Income -28.77M P/S 3.46 EPS this Y 60.60% Inst Trans -1.60% Short Ratio 5.32 Perf Half Y 4.48%
Sales 518.30M P/B 3.77 EPS next Y 64.10% ROA -4.60% Short Interest 2.55M Perf YTD 18.19%
Book/sh 9.59 P/C 12.14 EPS next 5Y - ROE -6.11% 52W High 43.11 -16.21% Perf Year 0.31%
Cash/sh 2.97 P/FCF 56.24 EPS past 3/5Y - -0.33% ROIC -5.17% 52W Low 28.29 27.68% Perf 3Y -20.96%
Dividend Est. - EV/EBITDA 160.41 Sales past 3/5Y 19.26% 15.05% Gross Margin 74.28% Volatility 6.08% 5.73% Perf 5Y -14.93%
Dividend TTM - EV/Sales 3.34 EPS Y/Y TTM 26.94% Oper. Margin -1.83% ATR (14) 1.76 Perf 10Y 76.54%
Dividend Ex-Date - Quick Ratio 2.85 Sales Y/Y TTM 15.80% Profit Margin -5.55% RSI (14) 55.28 Recom 1.00
Dividend Gr. 3/5Y - - Current Ratio 3.87 EPS Q/Q 96.64% SMA20 6.55% Beta 1.47 Target Price 51.67
Payout - Debt/Eq 0.17 Sales Q/Q 15.84% SMA50 2.83% Rel Volume 0.68 Prev Close 36.03
Employees 1300 LT Debt/Eq 0.17 Earnings Oct 29 AMC SMA200 5.54% Avg Volume 480.02K Price 36.12
IPO Aug 05, 2005 Option/Short Yes / Yes EPS/Sales Surpr. 91.06% 2.29% Trades
Volume 325,599 Change 0.25%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-17-24 Resumed JP Morgan
Overweight
$40
Apr-23-24 Upgrade Oppenheimer
Perform → Outperform
$32
Oct-23-23 Initiated JMP Securities
Mkt Outperform
$60
Sep-29-23 Initiated UBS
Buy
$56
Aug-05-21 Downgrade Oppenheimer
Outperform → Perform
Dec-18-20 Reiterated Needham
Buy
$53 → $63
Nov-06-20 Reiterated Needham
Buy
$63 → $53
Apr-07-20 Initiated Oppenheimer
Outperform
$45
Feb-06-20 Initiated BTIG Research
Buy
$42
Jan-24-20 Reiterated Needham
Buy
$39 → $48
Aug-13-19 Downgrade Northland Capital
Outperform → Market Perform
$30
Apr-12-19 Initiated JP Morgan
Overweight
$37
Oct-04-18 Reiterated Needham
Buy
$36 → $39
Aug-02-18 Reiterated Stifel
Buy
$32 → $34
Aug-02-18 Reiterated Needham
Buy
$32 → $36
Jun-18-18 Reiterated Needham
Buy
$26 → $32
Apr-27-18 Reiterated Needham
Buy
$23 → $26
Jan-16-18 Reiterated Needham
Buy
$25 → $23
Nov-02-17 Reiterated Needham
Buy
$26 → $25
Jul-28-17 Reiterated Needham
Buy
$25 → $26
Show Previous Ratings
Nov-25-25 09:55AM
Nov-20-25 09:40AM
Nov-18-25 08:00AM
Nov-07-25 09:35AM
Nov-06-25 02:16AM
09:40AM
Loading…
Nov-04-25 09:40AM
Oct-29-25 05:30PM
05:10PM
04:06PM
(Associated Press Finance)
04:01PM
Oct-28-25 09:46AM
08:00AM
Oct-27-25 08:00AM
Oct-08-25 08:00AM
Oct-03-25 05:54AM
08:08AM
Loading…
Sep-09-25 08:08AM
08:00AM
Aug-20-25 08:00AM
Jul-30-25 03:16AM
Jul-29-25 05:30PM
05:10PM
04:08PM
(Associated Press Finance)
04:01PM
Jul-28-25 08:00AM
Jul-17-25 08:40AM
Jul-15-25 08:00AM
Jul-08-25 08:00AM
Jun-30-25 09:40AM
Jun-12-25 09:40AM
May-27-25 09:40AM
08:00AM
Loading…
May-23-25 08:00AM
May-15-25 09:55AM
Apr-30-25 08:07AM
(Thomson Reuters StreetEvents) -13.68%
03:15AM
Apr-29-25 09:34PM
05:30PM
05:10PM
04:07PM
(Associated Press Finance)
04:01PM
Apr-10-25 11:37AM
08:00AM
Apr-09-25 08:10AM
Apr-08-25 12:18PM
08:00AM
Mar-12-25 08:00AM
Feb-13-25 12:00PM
10:29AM
(Thomson Reuters StreetEvents)
02:16AM
Feb-12-25 05:30PM
05:15PM
04:38PM
(Associated Press Finance)
04:01PM
Feb-11-25 09:15AM
Feb-05-25 10:00AM
Jan-23-25 06:26PM
Jan-22-25 08:00AM
Jan-13-25 08:00AM
Dec-23-24 08:00AM
Nov-20-24 08:00AM
Nov-07-24 08:00AM
Oct-30-24 10:19AM
(Thomson Reuters StreetEvents) +18.35%
03:12AM
Oct-29-24 07:00PM
05:10PM
04:07PM
(Associated Press Finance)
04:01PM
Oct-28-24 08:00AM
Oct-15-24 08:00AM
Oct-08-24 08:00AM
Oct-01-24 08:00AM
Sep-18-24 10:43AM
Aug-28-24 06:32AM
Aug-27-24 08:00AM
Aug-23-24 12:07PM
Aug-22-24 08:00AM
Jul-30-24 05:30PM
05:10PM
04:09PM
(Associated Press Finance)
04:01PM
Jul-29-24 08:00AM
Jul-24-24 10:14AM
Jul-23-24 08:00AM
Jul-09-24 08:00AM
Jun-28-24 06:50AM
Jun-21-24 01:44AM
May-31-24 07:00PM
May-15-24 08:00AM
May-02-24 03:18PM
08:36AM
03:49AM
May-01-24 08:57PM
08:00PM
05:55PM
05:30PM
04:34PM
(Associated Press Finance)
04:01PM
Apr-30-24 08:00AM
Apr-23-24 07:07AM
Apr-19-24 09:45AM
Apr-18-24 08:00AM
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
WEHRWEIN SVEN Director Nov 24 '25 Option Exercise 19.95 5,033 100,408 39,407 Nov 26 04:43 PM WEHRWEIN SVEN Director Nov 25 '25 Option Exercise 19.95 4,967 99,092 39,341 Nov 26 04:43 PM WEHRWEIN SVEN Director Nov 25 '25 Sale 38.00 4,967 188,746 34,374 Nov 26 04:43 PM WEHRWEIN SVEN Director Nov 24 '25 Sale 37.32 5,033 187,832 34,374 Nov 26 04:43 PM Noznesky Justin J Chief Mktg & Strategy Officer Nov 26 '25 Sale 37.29 5,166 192,640 78,798 Nov 26 04:41 PM Noznesky Justin J Officer Nov 26 '25 Proposed Sale 37.29 5,166 192,642 Nov 26 11:48 AM SVEN WEHRWEIN Director Nov 25 '25 Proposed Sale 38.00 4,967 188,746 Nov 25 04:06 PM Yuen Maggie Director Nov 21 '25 Sale 35.72 3,000 107,160 11,371 Nov 25 09:01 AM SVEN WEHRWEIN Director Nov 24 '25 Proposed Sale 37.32 5,033 187,854 Nov 24 05:41 PM MAGGIE YUEN Director Nov 21 '25 Proposed Sale 35.72 3,000 107,158 Nov 21 05:53 PM Noznesky Justin J Chief Mktg & Strategy Officer Sep 12 '25 Sale 36.30 3,000 108,900 83,964 Sep 16 08:45 AM Noznesky Justin J Officer Sep 12 '25 Proposed Sale 36.30 3,000 108,891 Sep 12 02:17 PM WEHRWEIN SVEN Director Aug 22 '25 Option Exercise 19.95 5,000 99,750 39,374 Aug 26 08:27 AM WEHRWEIN SVEN Director Aug 22 '25 Sale 37.00 5,000 185,000 34,374 Aug 26 08:27 AM SVEN WEHRWEIN Director Aug 22 '25 Proposed Sale 37.00 5,000 185,000 Aug 22 04:01 PM WEHRWEIN SVEN Director Aug 19 '25 Option Exercise 19.95 5,000 99,750 39,374 Aug 21 09:04 AM WEHRWEIN SVEN Director Aug 19 '25 Sale 36.00 5,000 180,000 34,374 Aug 21 09:04 AM SVEN WEHRWEIN Director Aug 19 '25 Proposed Sale 36.00 5,000 180,000 Aug 19 04:12 PM GROVES REGINA E Director Aug 06 '25 Sale 36.82 2,452 90,283 33,715 Aug 08 09:12 AM Doraiswamy Vinayak Chief Scientific Officer Aug 05 '25 Sale 36.58 2,500 91,450 71,872 Aug 07 08:45 AM GROVES REGINA E Director Aug 06 '25 Proposed Sale 36.83 2,452 90,307 Aug 06 10:38 AM VINAYAK DORAISWAMY Officer Aug 05 '25 Proposed Sale 36.58 2,500 91,442 Aug 05 04:08 PM Doraiswamy Vinayak Chief Scientific Officer May 28 '25 Sale 33.44 2,500 83,600 73,550 May 30 04:21 PM VINAYAK DORAISWAMY Officer May 28 '25 Proposed Sale 33.44 2,500 83,600 May 28 04:02 PM WHITE ROBERT S. Director May 05 '25 Option Exercise 22.62 10,000 226,200 106,773 May 07 08:25 AM Prange Karen Director Mar 05 '25 Sale 38.12 6,100 232,532 17,828 Mar 07 08:21 AM Prange Karen Director Mar 05 '25 Proposed Sale 38.04 6,100 232,044 Mar 05 10:02 AM
